Receive Breaking News updates as they occur
Colon cancer among people under 50 is on the rise, and tumors are often diagnosed at an advanced stage, according to research presented Tuesday. "While the healthcare system has done a great deal to address colorectal cancer in people over 50 -- heightening patient awareness and increasing screenings -- our findings show that much more needs to be done to fight this cancer in people under 50, a group not normally considered at risk," said lead author Elie Sutton, a research fellow at Mt. Sinai West Hospital in New York. "Not only did we find that the rate of colorectal cancer in this group is rising, we also saw that within the group that was diagnosed at a younger age, a higher percentage were diagnosed at later stages of cancer (stage three or four), which is very concerning," she added.
Monsanto's decision, first reported earlier on Tuesday by Reuters, puts pressure on Bayer to decide whether to raise its bid, even as the company faces criticism from some shareholders that its $122-per-share cash offer is already too high. The other options are to walk away, or mount a hostile bid. Bayer offered no immediate comment.
The world's largest brewer Anheuser-Busch InBev gained EU antitrust approval on Tuesday for its $100 billion-plus acquisition of SABMiller on condition it sell almost the whole of SABMiller's beer business in Europe. Reuters was the first to report that AB InBev's concessions to sell substantial assets would secure the EU green light for one of the largest corporate takeovers ever. AB InBev has already agreed to sell SABMiller's Peroni, Grolsch and Meantime beer brands to Japan's Asahi Group Holdings Ltd and to divest eastern European assets, three people familiar with the matter said on Friday.